The IV tubing sets and accessories market size was valued at USD 1.23 billion in 2024. The market is projected to grow from USD 1.28 billion in 2025 to USD 1.97 billion by 2034, exhibiting a CAGR of 4.9% during 2025–2034.
Intravenous (IV) tubing sets and accessories are essential components in the administration of IV therapy, which delivers fluids, medications, and nutrients directly into a patient's bloodstream. These sets are designed to optimize the infusion process, ensuring that treatments are delivered safely and effectively while minimizing the risk of infection and complications.
The rising prevalence of various chronic diseases such as cardiovascular conditions, diabetes, and cancer is driving the global IV tubing sets and accessories market growth. According to a report published by the National Library of Medicine, approximately one in three of all adults suffer from multiple chronic conditions (MCCs) globally. Chronic diseases typically cause complications, which lead to frequent hospital visits and admissions. In such cases, IV therapy is essential to treat these conditions effectively. IV tubing sets and accessories are required extensively in IV therapy for medication, hydration, and nutrition delivery directly into a patient's bloodstream.
To Understand More About this Research: Request a Free Sample Report
The rising geriatric population across the world drives the IV tubing sets and accessories market growth. As per data published by the United Nations, the number of people aged 65 years and above worldwide is projected to more than double, rising from 761 million in 2021 to 1.6 billion by 2050. Elderly patients tend to have more hospital admissions due to acute or chronic health issues, leading to increased use of IV therapy during admissions. This propels demand for IV tubing sets and accessories, which are used in IV therapy.
Advancements in healthcare infrastructure lead to increased accessibility to medical services. This accessibility encourages more individuals to seek medical attention, leading to higher rates of hospitalization and outpatient visits, where IV therapy is essential for treating conditions such as dehydration and infections or those undergoing chemotherapy. Therefore, the rising advancements in healthcare infrastructure across the world propel the global IV tubing sets and accessories market expansion.
New product launches include advancements in safety features, such as anti-kink designs, secure connectors, and integrated filters. These improvements reduce the risk of complications, making healthcare providers more likely to choose the latest options, thus increasing overall demand. In July 2022, B. Braun Medical Inc., a major player in infusion therapy, announced the launch of its new Introcan Safety 2 IV Catheter with one-time blood control. The Introcan Safety 2 IV Catheter is developed to make IV access safer for the clinician by reducing the risk of needlestick injuries and exposure to blood. Thus, the increasing product development and launches fuel the growth of the IV tubing sets and accessories market.
Based on product, the IV tubing sets and accessories market is segmented into primary IV tubing sets, secondary IV tubing sets, extension IV tubing sets, IV tubing accessories, and others. The primary IV tubing sets segment accounted for a major market share in 2024 due to their essential role in the administration of intravenous therapies across various healthcare settings. The widespread use of these sets in hospitals and clinics arises from their critical function in delivering medications, fluids, and nutrients directly into patients' circulatory systems. The growing prevalence of chronic diseases, coupled with an increasing number of surgical procedures, drives demand for primary tubing sets. Healthcare providers prioritize these systems for their reliability and efficiency in ensuring patient safety and treatment efficacy. Additionally, technological advancements such as the integration of smart infusion pumps with primary tubing enhance the user experience and contribute to the segment's dominant position.
The extension IV tubing sets segment is expected to grow at a robust pace in the coming years, owing to the rising trend toward home healthcare and outpatient services, where patients require additional length to facilitate convenient administration of therapies. Extension sets allow for greater flexibility and mobility, making them ideal for home-based care, especially among the aging population and those with chronic conditions. Moreover, healthcare facilities are increasingly adopting these extension sets to accommodate complex treatment procedures where multiple medications may need to be administered altogether. The increasing focus on patient comfort and autonomy, along with innovations that enhance the functionality of extension tubing, positions this segment for continued expansion.
In terms of application, the IV tubing sets and accessories market is segmented into peripheral intravenous catheter insertion, central venous catheter placement, and PICC line insertion. The peripheral intravenous catheter insertion segment held the largest market share in 2024 due to its widespread use across various healthcare settings, including hospitals, outpatient clinics, and emergency departments. Peripheral catheters facilitate the rapid delivery of fluids, medications, and blood products, making them essential for patient care. The increasing incidence of chronic diseases, such as diabetes and hypertension, drives higher rates of hospitalizations and outpatient visits, further enhancing the demand for peripheral access. Additionally, advancements in catheters, such as improved materials that reduce discomfort and infection risk, support the growing preference for peripheral insertions among healthcare providers.
The central venous catheter placement segment is projected to grow at a rapid pace during the forecast period owing to the rising complexity of medical treatments, particularly in oncology and critical care, where central venous access becomes essential for administering prolonged therapies, high-flow medications, and parenteral nutrition. The demand for central venous catheters continues to rise as healthcare providers increasingly adopt multi-modal treatment approaches that require simultaneous administration of various drugs. Additionally, ongoing training programs and improved placement techniques enhance the safety and efficacy of these devices, making them more appealing to clinicians, which ultimately increases their adoption.
By region, the study provides the IV tubing sets and accessories market insights into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America held the largest market share in 2024 due to advanced healthcare infrastructure, high prevalence of chronic diseases, and a rising number of surgical procedures requiring intravenous access. The US healthcare system prioritizes quality patient care, leading to a robust demand for reliable and efficient intravenous therapy solutions. Furthermore, the increasing adoption of innovative technologies and continuous product development in this region enhances treatment options, making healthcare providers more likely to utilize IV tubing sets and accessories. The combination of a well-established medical supply industry and ongoing investments in healthcare further contributes to North America's dominant position in the global market.
The Asia Pacific IV tubing sets and accessories market is expected to register a significant CAGR during the forecast period due to rapid economic growth, rising urbanization, and an expanding healthcare infrastructure. Countries such as China and India are at the forefront of this growth, driven by increasing healthcare expenditures and a rising population with evolving healthcare needs. The demand for intravenous therapy solutions is expected to rise significantly in the coming years as these nations enhance their medical facilities and improve access to quality healthcare. The increased awareness of advanced medical technologies and improved healthcare policies facilitate market expansion in Asia Pacific. Additionally, the growing prevalence of chronic diseases and an increasing aging population in these countries propel the need for effective intravenous treatments, which propels the demand for IV tubing sets and accessories. According to the World Health Organization, 402 million people (28% of the total population) will be over the age of 60 in China by 2040.
Key market players are investing heavily in research and development to expand their offerings, which will help the IV tubing sets and accessories market grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments such as innovative launches, international collaborations, higher investments, and mergers and acquisitions between organizations.
The IV tubing sets and accessories market is fragmented, with the presence of numerous global and regional market players. A few major players in the market are Polymedicure; Nipro Medical Corporation; Fresenius Kabi AG; BD; Baxter; ICU Medical, Inc.; B. Braun Medical Inc.; and Zyno Medical LLC.
B. Braun Medical Inc. is a global player in the healthcare sector, specializing in the development and manufacturing of medical devices and pharmaceutical products, particularly in the field of intravenous (IV) therapy. The company’s extensive range of IV tubing sets and accessories is designed to enhance patient safety and comfort while ensuring effective delivery of medications and fluids. B. Braun's commitment to quality and innovation is reflected in its advanced IV solutions, which cater to various clinical needs across different healthcare settings.
Polymedicure, a major manufacturer in the medical device industry, specializes in providing high-quality intravenous (IV) tubing sets and accessories designed to enhance patient care and safety during IV therapy. Polymedicure has developed a comprehensive range of IV products that cater to the diverse needs of healthcare professionals across various clinical settings. The company's offerings include advanced IV infusion sets, which are crucial for the effective delivery of medications, fluids, and nutrients directly into a patient's bloodstream.
September 2024: B. Braun Medical Inc., a global player in smart infusion therapy and pain management, announced that the US Food and Drug Administration (FDA) had granted 510(k) clearance for the Introcan Safety 2 Deep Access IV Catheter, the newest addition to the Introcan Safety 2 IV Catheter portfolio.
August 2023: ICU Medical Inc., a prominent company involved in the development, manufacture, and sale of innovative medical devices, announced that the company had received 510(k) regulatory clearance from the FDA for the Plum Duo infusion pump with LifeShield infusion safety software. The Plum Duo pump is the newest addition to ICU Medical's portfolio of infusion devices.
Report Attributes |
Details |
Market Size Value in 2024 |
USD 1.23 Billion |
Market Size Value in 2025 |
USD 1.28 Billion |
Revenue Forecast by 2034 |
USD 1.97 Billion |
CAGR |
4.9% from 2025 to 2034 |
Base Year |
2024 |
Historical Data |
2020–2023 |
Forecast Period |
2025–2034 |
Quantitative Units |
Revenue in USD Billion and CAGR from 2025 to 2034 |
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
Segments Covered |
|
Regional Scope |
|
Competitive Landscape |
|
Report Format |
|
Customization |
Report customization as per your requirements with respect to countries, regions, and segmentation. |
The global IV tubing sets and accessories market size was valued at USD 1.23 billion in 2024 and is projected to grow to USD 1.97 billion by 2034.
The global market is projected to register a CAGR of 4.9% during the forecast period.
North America accounted for the largest share of the global market in 2024.
A few key players in the market are Polymedicure; Nipro Medical Corporation; Fresenius Kabi AG; BD; Baxter; ICU Medical, Inc.; B. Braun Medical Inc.; and Zyno Medical LLC
The extension IV tubing sets segment is projected for significant growth in the global market during the forecast period.
The peripheral intravenous catheter insertion segment dominated the market in 2024.